BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 15068396)

  • 1. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
    Dauksaite V; Akusjärvi G
    J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
    Gao H; Gordon-Kamm WJ; Lyznik LA
    Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Liu X; Mayeda A; Tao M; Zheng ZM
    J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.
    Molin M; Akusjärvi G
    J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
    Wang J; Manley JL
    RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA recognition motif 2 directs the recruitment of SF2/ASF to nuclear stress bodies.
    Chiodi I; Corioni M; Giordano M; Valgardsdottir R; Ghigna C; Cobianchi F; Xu RM; Riva S; Biamonti G
    Nucleic Acids Res; 2004; 32(14):4127-36. PubMed ID: 15302913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
    Shih SR; Krug RM
    EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titration of serine/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing.
    Himmelspach M; Cavaloc Y; Chebli K; Stévenin J; Gattoni R
    RNA; 1995 Oct; 1(8):794-806. PubMed ID: 7493325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
    Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
    J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIR, a corepressor of CBF1, binds to PAP-1 and effects alternative splicing.
    Maita H; Kitaura H; Ariga H; Iguchi-Ariga SM
    Exp Cell Res; 2005 Feb; 303(2):375-87. PubMed ID: 15652350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
    Cao W; Jamison SF; Garcia-Blanco MA
    RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XE7: a novel splicing factor that interacts with ASF/SF2 and ZNF265.
    Mangs AH; Speirs HJ; Goy C; Adams DJ; Markus MA; Morris BJ
    Nucleic Acids Res; 2006; 34(17):4976-86. PubMed ID: 16982639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
    Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
    PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
    Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
    Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
    Jumaa H; Nielsen PJ
    EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single RNA recognition motif in splicing factor ASF/SF2 directs it to nuclear sites of adenovirus transcription.
    Lindberg A; Gama-Carvalho M; Carmo-Fonseca M; Kreivi JP
    J Gen Virol; 2004 Mar; 85(Pt 3):603-608. PubMed ID: 14993643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
    Cao W; Garcia-Blanco MA
    J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.